{"entity":{"type":"insider","cik":"0001894425","url":"/insider/0001894425","json_url":"/insider/0001894425.json","name":"Onyia Jude","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":14,"first":"2022-12-01","last":"2026-06-02","span_basis":"filed_date"},"name_variants":[{"name":"Onyia Jude","source":"filing","n_filings":14,"first_seen":"2022-12-01","last_seen":"2026-06-02"}],"transactions":[{"id":5951155,"accession":"0001894425-26-000012","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001894425-26-000012","line_url":"/filing/0001894425-26-000012#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001894425","owner_name":"Onyia Jude","owner_display_name":"Onyia Jude","owner_url":"/insider/0001894425","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11000.0,"shares_display":"11,000","price_per_share":160.2464,"price_display":"160.25","price_state":"stated","total_value":1762710.4,"total_display":"1,762,710.40","total_whole":"1,762,710","shares_owned_after":25846.0,"shares_owned_after_display":"25,846","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-01","filed_date":"2026-06-02","scope":"insider"},{"id":5819454,"accession":"0001894425-26-000010","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001894425-26-000010","line_url":"/filing/0001894425-26-000010#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001894425","owner_name":"Onyia Jude","owner_display_name":"Onyia Jude","owner_url":"/insider/0001894425","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11000.0,"shares_display":"11,000","price_per_share":155.5332,"price_display":"155.53","price_state":"stated","total_value":1710865.2,"total_display":"1,710,865.20","total_whole":"1,710,865","shares_owned_after":25846.0,"shares_owned_after_display":"25,846","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-27","filed_date":"2026-05-29","scope":"insider"},{"id":5067318,"accession":"0000914475-25-000151","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000914475-25-000151","line_url":"/filing/0000914475-25-000151#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001894425","owner_name":"Onyia Jude","owner_display_name":"Onyia Jude","owner_url":"/insider/0001894425","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":59819.0,"shares_display":"59,819","price_per_share":130.455,"price_display":"130.46","price_state":"stated","total_value":7803687.645,"total_display":"7,803,687.64","total_whole":"7,803,688","shares_owned_after":18289.0,"shares_owned_after_display":"18,289","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-09","filed_date":"2025-07-11","scope":"insider"},{"id":4698203,"accession":"0000914475-25-000149","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000914475-25-000149","line_url":"/filing/0000914475-25-000149#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001894425","owner_name":"Onyia Jude","owner_display_name":"Onyia Jude","owner_url":"/insider/0001894425","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20362.0,"shares_display":"20,362","price_per_share":130.1315,"price_display":"130.13","price_state":"stated","total_value":2649737.603,"total_display":"2,649,737.60","total_whole":"2,649,738","shares_owned_after":18289.0,"shares_owned_after_display":"18,289","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-02","filed_date":"2025-07-07","scope":"insider"},{"id":4789138,"accession":"0000914475-25-000067","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000914475-25-000067","line_url":"/filing/0000914475-25-000067","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001894425","owner_name":"Onyia Jude","owner_display_name":"Onyia Jude","owner_url":"/insider/0001894425","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2879.0,"shares_display":"2,879","price_per_share":116.79007492184786,"price_display":"116.79","price_state":"stated","total_value":336238.6257,"total_display":"336,238.63","total_whole":"336,239","shares_owned_after":18089.0,"shares_owned_after_display":"18,089","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-13","filed_date":"2025-02-14","scope":"insider","n_lines":2},{"id":4162280,"accession":"0000914475-25-000027","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000914475-25-000027","line_url":"/filing/0000914475-25-000027#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001894425","owner_name":"Onyia Jude","owner_display_name":"Onyia Jude","owner_url":"/insider/0001894425","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":126.0,"shares_display":"126","price_per_share":152.9681,"price_display":"152.97","price_state":"stated","total_value":19273.9806,"total_display":"19,273.98","total_whole":"19,274","shares_owned_after":15561.0,"shares_owned_after_display":"15,561","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-31","filed_date":"2025-02-04","scope":"insider"},{"id":3246094,"accession":"0000914475-24-000222","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000914475-24-000222","line_url":"/filing/0000914475-24-000222#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001894425","owner_name":"Onyia Jude","owner_display_name":"Onyia Jude","owner_url":"/insider/0001894425","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2331.0,"shares_display":"2,331","price_per_share":126.286,"price_display":"126.29","price_state":"stated","total_value":294372.666,"total_display":"294,372.67","total_whole":"294,373","shares_owned_after":15449.0,"shares_owned_after_display":"15,449","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-29","filed_date":"2024-12-03","scope":"insider"},{"id":2201412,"accession":"0000914475-24-000075","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914475-24-000075","line_url":"/filing/0000914475-24-000075#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001894425","owner_name":"Onyia Jude","owner_display_name":"Onyia Jude","owner_url":"/insider/0001894425","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1432.0,"shares_display":"1,432","price_per_share":132.9407,"price_display":"132.94","price_state":"stated","total_value":190371.0824,"total_display":"190,371.08","total_whole":"190,371","shares_owned_after":13128.0,"shares_owned_after_display":"13,128","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-13","filed_date":"2024-02-15","scope":"insider"},{"id":2942248,"accession":"0000914475-24-000030","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914475-24-000030","line_url":"/filing/0000914475-24-000030#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001894425","owner_name":"Onyia Jude","owner_display_name":"Onyia Jude","owner_url":"/insider/0001894425","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":126.0,"shares_display":"126","price_per_share":141.94,"price_display":"141.94","price_state":"stated","total_value":17884.44,"total_display":"17,884.44","total_whole":"17,884","shares_owned_after":11843.0,"shares_owned_after_display":"11,843","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-31","filed_date":"2024-02-02","scope":"insider"},{"id":7955455,"accession":"0001209191-23-057097","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-057097","line_url":"/filing/0001209191-23-057097#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001894425","owner_name":"Onyia Jude","owner_display_name":"Onyia Jude","owner_url":"/insider/0001894425","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2331.0,"shares_display":"2,331","price_per_share":113.5705,"price_display":"113.57","price_state":"stated","total_value":264732.8355,"total_display":"264,732.84","total_whole":"264,733","shares_owned_after":11732.0,"shares_owned_after_display":"11,732","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-29","filed_date":"2023-12-01","scope":"insider"},{"id":7923204,"accession":"0001209191-23-047139","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-047139","line_url":"/filing/0001209191-23-047139#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001894425","owner_name":"Onyia Jude","owner_display_name":"Onyia Jude","owner_url":"/insider/0001894425","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3198.0,"shares_display":"3,198","price_per_share":107.3696,"price_display":"107.37","price_state":"stated","total_value":343367.9808,"total_display":"343,367.98","total_whole":"343,368","shares_owned_after":9638.0,"shares_owned_after_display":"9,638","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-21","filed_date":"2023-08-23","scope":"insider"},{"id":7867545,"accession":"0001209191-23-007915","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-007915","line_url":"/filing/0001209191-23-007915#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001894425","owner_name":"Onyia Jude","owner_display_name":"Onyia Jude","owner_url":"/insider/0001894425","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4508.0,"shares_display":"4,508","price_per_share":102.2995,"price_display":"102.30","price_state":"stated","total_value":461166.146,"total_display":"461,166.15","total_whole":"461,166","shares_owned_after":6525.0,"shares_owned_after_display":"6,525","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-07","filed_date":"2023-02-08","scope":"insider"},{"id":7867494,"accession":"0001209191-23-006281","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-006281","line_url":"/filing/0001209191-23-006281#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001894425","owner_name":"Onyia Jude","owner_display_name":"Onyia Jude","owner_url":"/insider/0001894425","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":126.0,"shares_display":"126","price_per_share":108.48,"price_display":"108.48","price_state":"stated","total_value":13668.48,"total_display":"13,668.48","total_whole":"13,668","shares_owned_after":2477.0,"shares_owned_after_display":"2,477","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-31","filed_date":"2023-02-02","scope":"insider"},{"id":6466099,"accession":"0001209191-22-059242","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-059242","line_url":"/filing/0001209191-22-059242#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001894425","owner_name":"Onyia Jude","owner_display_name":"Onyia Jude","owner_url":"/insider/0001894425","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2331.0,"shares_display":"2,331","price_per_share":121.9048,"price_display":"121.90","price_state":"stated","total_value":284160.0888,"total_display":"284,160.09","total_whole":"284,160","shares_owned_after":2366.0,"shares_owned_after_display":"2,366","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-29","filed_date":"2022-12-01","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":15,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":15,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":15},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000914475","name":"NEUROCRINE BIOSCIENCES INC","url":"/issuer/0000914475","role":"Officer (Chief Scientific Officer)","n_filings":14,"first_seen":"2022-12-01","last_seen":"2026-06-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001894425","retrieved_at":"2026-08-25T17:38:38+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}